Saudi hospitals urged to partake in COVID-19 studies

(SPA)
Short Url
Updated 01 July 2020

Saudi hospitals urged to partake in COVID-19 studies

RIYADH: The King Abdullah International Medical Research Center (KAIMRC) has urged all Saudi hospitals to take part in clinical studies accredited by the Saudi Food and Drug Authority to find treatments for COVID-19.  
KAIMRC is conducting clinical studies to find treatments by using different anti-viral drugs. The first study is testing the drug favipiravir, developed in Japan and used in mild cases.
The second study is being conducted in cooperation with the Health Ministry to test a combination of two drugs, favipiravir and hydroxychloroquine (an anti-malarial drug), with specific doses, to be adopted in moderate to severe cases.
The third study, conducted under the ministry’s patronage, aims to test the possibility of extracting blood plasma from people who have recovered from COVID-19 to treat critical cases where patients need ventilators or oxygen masks.
The fourth study is being conducted to compare treatment protocols used for several groups to identify the best one.
Dr. Ahmed Al-Askar, executive director of KAIMRC, said hospitals’ participation in these studies is necessary to trace the effects and results of the drugs on patients and compare them with people who have not received the experimental treatments.


Saudi Arabia and UN's fight against terrorism lauded at launch of 'virtual expo'

Updated 08 July 2020

Saudi Arabia and UN's fight against terrorism lauded at launch of 'virtual expo'

  • The UNCCT was set up in 2011 to promote international counter-terrorism cooperation

LONDON: Saudi Arabia has been a crucial partner alongside the United Nations in countering terrorism, the Kingdom’s UN ambassador said.

Abdallah Al-Mouallimi made the comments as the United Nations Counter-Terrorism Centre (UNCCT) launched on Tuesday a “virtual expo” into its work.

“The Kingdom of Saudi Arabia has been a crucial partner alongside the United Nations in countering terrorism and extremism,” Al-Mouallimi, who is chairman of the center’s advisory board, said.

“It is my intention to underscore the continued Saudi support for the UNCCT as the Centre of Excellence in countering terrorism,” he added.

The UNCCT was set up in 2011 to promote international counter-terrorism cooperation and support member states implement the global counter-terrorism strategy. Saudi Arabia funded the project with $110 million.

Al-Mouallimi hosted the launch of the virtual expo on Tuesday. 

The expo “showcases the Centre as a global leader in preventing and countering terrorism and violent extremism through capacity‑building efforts around the world,” the UNCCT said.

The virtual expo will run for four weeks online.